CardioThoracic Systems, Inc. (extinct)

CardioThoracic Systems, Inc. (extinct)

CardioThoracic Systems, Inc. (extinct)

Overview
Headquarters

10600 North Tantau Avenue,Cupertino, CA 95014

Type of Company

Private

Industries

Other Business & Consulting Services
Medical Products & Equipment

Company Description

CardioThoracic Systems, Inc., located in Cupertino, Calif., is a leadingdeveloper of proprietary technologies in minimally invasive cardiothoracicsurgery. CTS introduced its first generation system for minimally invasivebeating heart bypass surgery in January 1997. Since that time, over 11,000beating heart bypass procedures, including midline and thorocotomy approaches, have been performed using CTS' propriety instruments. CTS is also developing technologies in the area of minimally invasive valve repair. CardioThoracic Systems, Inc., has been acquired by Guidant in 1999.

Paths to CardioThoracic Systems, Inc.
Potential Connections via
Relationship Science
You
CardioThoracic Systems, Inc.
Recent Transactions
Details Hidden

Guidant Corporation purchases CardioThoracic Systems, Inc.

Details Hidden

CardioThoracic Systems, Inc. issued Common Stock

Transaction Advisors
Investment Advisor

Advised onGuidant Corporation purchases CardioThoracic Systems, Inc.

Investment Advisor

Advised onGuidant Corporation purchases CardioThoracic Systems, Inc.

Accountant

Advised onGuidant Corporation purchases CardioThoracic Systems, Inc.

Investors
Details Hidden

New Enterprise Associates (NEA) focuses on investments in the technology and healthcare sectors. The firm's investment strategy spans all stages of a company's growth, from seeding innovations in emerging markets to funding early-stage companies in high-growth markets to fueling the growth of market leaders. NEA actively invests in emerging markets, with emphasis on India and China.NEA's investments in the healthcare sector focus on companies that address unmet or underserved clinical needs and that combine improved clinical outcomes with lower costs to the market. The firm targets three areas including biopharmaceuticals, medical devices and healthcare services. The firm has a history of partnering with companies that have pioneered transformative innovations in healthcare, such as balloon angioplasty and laparoscopic surgeryWithin the technology sector, NEA focuses on investments in the electronics, consumer technology, enterprise mobility, virtualization, tech-enabled services, SaaS and cloud computing industries.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by CardioThoracic Systems, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of CardioThoracic Systems, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and CardioThoracic Systems, Inc..